全文获取类型
收费全文 | 70003篇 |
免费 | 5693篇 |
国内免费 | 224篇 |
专业分类
耳鼻咽喉 | 918篇 |
儿科学 | 1756篇 |
妇产科学 | 1126篇 |
基础医学 | 9008篇 |
口腔科学 | 1373篇 |
临床医学 | 7867篇 |
内科学 | 14874篇 |
皮肤病学 | 1096篇 |
神经病学 | 6207篇 |
特种医学 | 2623篇 |
外科学 | 11054篇 |
综合类 | 1291篇 |
现状与发展 | 1篇 |
一般理论 | 63篇 |
预防医学 | 6191篇 |
眼科学 | 938篇 |
药学 | 5067篇 |
中国医学 | 81篇 |
肿瘤学 | 4386篇 |
出版年
2023年 | 324篇 |
2022年 | 638篇 |
2021年 | 1519篇 |
2020年 | 854篇 |
2019年 | 1401篇 |
2018年 | 1657篇 |
2017年 | 1135篇 |
2016年 | 1346篇 |
2015年 | 1610篇 |
2014年 | 2140篇 |
2013年 | 2971篇 |
2012年 | 4700篇 |
2011年 | 4761篇 |
2010年 | 2635篇 |
2009年 | 2377篇 |
2008年 | 4058篇 |
2007年 | 4145篇 |
2006年 | 4103篇 |
2005年 | 4154篇 |
2004年 | 3761篇 |
2003年 | 3558篇 |
2002年 | 3309篇 |
2001年 | 1372篇 |
2000年 | 1281篇 |
1999年 | 1221篇 |
1998年 | 784篇 |
1997年 | 673篇 |
1996年 | 583篇 |
1995年 | 584篇 |
1994年 | 487篇 |
1993年 | 467篇 |
1992年 | 839篇 |
1991年 | 827篇 |
1990年 | 762篇 |
1989年 | 684篇 |
1988年 | 645篇 |
1987年 | 615篇 |
1986年 | 603篇 |
1985年 | 591篇 |
1984年 | 474篇 |
1983年 | 405篇 |
1982年 | 363篇 |
1981年 | 357篇 |
1980年 | 261篇 |
1979年 | 398篇 |
1978年 | 309篇 |
1977年 | 272篇 |
1976年 | 223篇 |
1974年 | 249篇 |
1973年 | 261篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Auda A. Eltahla Fabio Luciani Peter A. White Andrew R. Lloyd Rowena A. Bull 《Viruses》2015,7(10):5206-5224
The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success and vaccine development remains slow. The development of antiviral therapeutic agents has also been challenging, primarily due to the lack of efficient cell culture and animal models for all HCV genotypes, as well as the large genetic diversity between HCV strains. On the other hand, the use of interferon-α-based treatments in combination with the guanosine analogue, ribavirin, achieved limited success, and widespread use of these therapies has been hampered by prevalent side effects. For more than a decade, the HCV RNA-dependent RNA polymerase (RdRp) has been targeted for antiviral development. Direct acting antivirals (DAA) have been identified which bind to one of at least six RdRp inhibitor-binding sites, and are now becoming a mainstay of highly effective and well tolerated antiviral treatment for HCV infection. Here we review the different classes of RdRp inhibitors and their mode of action against HCV. Furthermore, the mechanism of antiviral resistance to each class is described, including naturally occurring resistance-associated variants (RAVs) in different viral strains and genotypes. Finally, we review the impact of these RAVs on treatment outcomes with the newly developed regimens. 相似文献
33.
34.
35.
Sirt5 is known to functionally regulate mitochondrial proteins by altering posttranslational modifications, including lysine desuccinylation. While roles for Sirt5 as either a tumor promoter or suppressor, or in chemoresistance, have been implicated in other cancers, the function of Sirt5 in cutaneous melanoma has not been well examined. Therefore, to determine whether Sirt5 is necessary for BrafV600E‐mediated melanoma formation and/or disease progression, we crossed a genetically engineered murine melanoma model (TyrCreERT2/+; BrafLSL‐V600E/+; Ptenflox/flox) to Sirt5?/? knockout animals. In addition, we tested for synergism with a selective BRAF (V600E) inhibitor in Sirt5?/? mouse melanoma cells. Taken together, this report demonstrates that, in these models, Sirt5 is dispensable for BrafV600E‐mediated cutaneous melanoma formation and growth in vivo, and does not improve sensitivity to a selective BRAF inhibitor. 相似文献
36.
37.
Phantana-angkool April Voci Amy E. Warren Yancey E. Livasy Chad A. Beasley Lakesha M. Robinson Myra M. Hadzikadic-Gusic Lejla Sarantou Terry Forster Meghan R. Sarma Deba White Richard L. 《Annals of surgical oncology》2019,26(12):3874-3882
Annals of Surgical Oncology - The role of sentinel lymph node biopsy (SLNB) when ductal carcinoma in situ with microinvasion (DCISM) is identified on core biopsy is unclear. Our aim was to assess... 相似文献
38.
39.
40.
Timothy W Puetz Kathryn M Beasman Patrick J O'Connor 《European journal of cardiovascular prevention and rehabilitation》2006,13(6):886-893
BACKGROUND: Physical activity is a healthful behavior that has promise for combating feelings of low energy and fatigue. Despite evidence suggesting that fatigue is a prodromal symptom of major cardiac events, improvements in feelings of energy and fatigue have largely been ignored by reviewers of cardiac rehabilitation literature who have focused on anxiety, depression and general measures of quality of life. DESIGN: A meta-analytical review. METHODS AND RESULTS: Computer databases were searched from January 1945 to May 2005 to identify relevant literature. A total of 36 studies consisting of 4765 subjects were included. Cardiac rehabilitation exercise programs were consistently associated with increases in energy and decreases in fatigue. The magnitude of the effect was moderately large (mean delta 0.51; 95% confidence interval 0.42-0.61) but was heterogeneous and modified by features of the research design. Comparison of effect sizes in cardiac rehabilitation studies concurrently measuring energy/fatigue, anxiety and depression suggest that exercise-based cardiac rehabilitation programs have larger effects on feelings of energy and fatigue compared with anxiety and depression. CONCLUSION: This review quantifies the potential benefit of cardiac rehabilitation exercise programs on feelings of energy and fatigue, and suggests that cardiac rehabilitation researchers and practitioners may benefit from examining, and perhaps even focusing on, feelings of energy and fatigue as an important outcome variable. A greater understanding of the effect of cardiac rehabilitation exercise programs on feelings of energy and fatigue will be reached when more true experiments are conducted thereby avoiding the primary limitation of the literature reviewed; that is, the frequent use of non-experimental research designs. 相似文献